Irish Medical Survey Reveals Support for Cannabis Decriminalization Among Doctors

A recent anonymous survey conducted by the Irish Medical Times has uncovered significant support for the decriminalization of small amounts of cannabis among Irish doctors. According to the survey, 54% of the participating physicians are in favor of this policy change. Despite the overwhelming belief that drug use negatively impacts health, with 95% of respondents agreeing, many doctors advocate for treating drug users within the healthcare system rather than criminalizing them

The survey included 89 doctors from various fields, including general practitioners and specialized consultants, ensuring a representative sample of the medical profession in Ireland. Participants were required to provide their medical registration numbers to verify their credentials. This survey marks the first time doctors in Ireland have been asked anonymously about their personal views on drug use and cannabis legalization, offering a rare glimpse into the medical community's stance on these issues

Terence Cosgrave, editor of the Irish Medical Times, highlighted the nuanced perspectives revealed by the survey. He noted that while some established medical figures oppose cannabis legalization, the broader medical community appears to support decriminalization, particularly for cannabis. Cosgrave also pointed out that 37% of doctors admitted to having tried cannabis, with 8% currently using it and 5% using it regularly, suggesting a more common personal use than previously acknowledged

The survey's findings arrive at a critical time, as Ireland's Citizen's Assembly on Drugs is in session. This assembly, comprising 99 public members, is tasked with providing recommendations on the country's drug policy to the Oireachtas. Early indications from the assembly suggest that the decriminalization of all drugs for personal use may be a key recommendation, aligning with the survey's results and reflecting a shift towards more progressive drug policies

Brendan Minish, an advocate for drug reform in Ireland, viewed the survey results positively but emphasized the need to address the stigma within the medical establishment. He questioned whether the survey reflects a genuine shift in opinion or simply provides a platform for doctors to express their views without fear of professional repercussions. As Ireland continues to debate its drug policies, these insights from the medical community could play a pivotal role in shaping future legislation